Sartorius will open a new state-of-the-art manufacturing facility in Havant, Hampshire, UK. More than 90 employees will relocate to the new facility near the former site in Portsmouth.
 
“The new facility in Havant will be an important part of our global operations network as it will enable our business to grow to meet the requirements of the expanding industry,” said Dr. Thorsten Peuker, Head of Operations, BPS Systems at Sartorius.
 
The 58,000-square-foot site will bring together skilled engineers with biochemical, electrical, and mechanical backgrounds who will design and manufacture a range of systems for the biopharmaceutical market, including chromatography columns and filtration systems. These systems are crucial for manufacturing injectable drugs used to treat cancer and diabetes and for producing vaccines.
 
In addition to a 28,000-square-foot production area, the center accommodates a 4,000-square-foot customer test lab to demonstrate the functionality of Sartorius equipment. “The new facility increases Sartorius’ capacity to deliver support in all areas of our business and provide the highest quality equipment and services to our customers,” said Peuker.
 
In 2021, Sartorius plans to invest more than 400 million euros to expand manufacturing capacities around the world to meet growing demand from the biopharmaceuticals market. Sartorius aims to expand its Havant site, and the company is now offering positions for process engineers, project managers, and design engineers, as well as for several support functions, among other job vacancies. With its new facility in Havant, Sartorius now has five locations in the UK.